How nutrient and nutraceuticals modulate genetic expressions in cardiovascular disease?

World Heart Journal

Volumn 3, Issue 1, 2010, Pages 73-86

  Fedacko, Jan ^a   Vargoa, Viola ^a   Singh, R B ^a   De Meester, Fabien ^a   Pella, Daniel ^a   Juneja, Lekh R ^a  

^a NONE

Author keywords

Chromosome vrient; Epigenetics; Proteome; Single nucleotide polymorphism; Transcription factor

Indexed keywords

ANTIOXIDANT; BLOOD CLOTTING FACTOR; CARBOHYDRATE; CHROMIUM; COPPER; EARLY GROWTH RESPONSE FACTOR 1; FLUORIDE; FREE RADICAL; IRON; LINOLEIC ACID; LIPOPROTEIN; MAGNESIUM; MANGANESE; MATRIX METALLOPROTEINASE; MINERAL; MONOUNSATURATED FATTY ACID; NUCLEAR FACTOR; NUTRACEUTICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM; SATURATED FATTY ACID; SELENIUM; SUPEROXIDE; TRACE ELEMENT; TRANS FATTY ACID; TRANSCRIPTION FACTOR; UBIDECARENONE; UNINDEXED DRUG; VITAMIN; ZINC;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FOOD INTAKE; FUNCTIONAL FOOD; GENE EXPRESSION; GENE INTERACTION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GLUCOSE INTAKE; HERITABILITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LEUKOCYTE; LIFESTYLE; LIPID METABOLISM; LIPOGENESIS; MILK; MONONUCLEAR CELL; MORTALITY; MULTIFACTORIAL GENETIC DISORDER; MULTINUCLEAR CELL; NEOPLASM; NUTRIENT; NUTRITIONAL STATUS; OBESITY; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR DISEASE;

EID: 77956664407     PISSN: 15564002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Singh RB,Niaz MA. Genetic variation and nutrition, in relation to coronary artery disease. J. Asso. Phys. India 1999,47:1185-1190.
2. Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology in to clinical applications. Can. Med. Asso. J. 2006; 174: 341-348.
3. Jones PA, Baylin SB. The epigenomics of cancer.Cell 2007; 128:683-69
4. Trojer P, Reinberg D. Histone, lysine, demethylases and their impact on epigenetics. Cell 2006,125: 213-217.
5. Scriver CR. Nutrient gene interactions: the gene is not the disease and viceversa..Am. J. Clin. Nutr. 1988, 48:1505-1509.
6. Masuzaki H, Paterson J, Shinayama H et al.A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294:2166/70.
7. Bensatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 2004, 23: 281-302.
8. Berdanier CD, Hargrove JL. Nutrition and Gene Expression. CRC Press, Boca Raton, USA 1993,10-20.
9. Isles AR, Wilkilson LS. Epigenetics: what is it and why it is important to mental diseases. BMJ 2008; 85:35-45.
10. Singh RB, De Meester F.How clock genes influence heart attack rate in the morning?Response letter to editor. Science online 2008, 22:27
11. Dolgin E.( Keegan K and Allada R) .Unlocking the clock. Scientist 2008, 22: 27.
12. Conrad DF, Andrews TD, Carter NP et al., A high-resolution survey of deletion polymorphism in the human genome. Nat. Genet, 38:75-81, 2006. (Cited in 149 papers).
13. McCarroll SA, Hadnott TN, Perry GH et al., Common deletion polymorphisms in the human genome, Nat. Genet., 38:86-92, 2006. (Cited in 152 papers)
14. Redon R , Ishikawa S, Fitch KR et al., "Global variation in copy number in the human genome," Nature, 444:444-54, 2006.
15. Mills RE, Luttig CT, Larkins CE et al., "An initial map of insertion and deletion (INDEL) variation in the human genome," Genome Res, 16:1182-90, 2006.
16. Levy S, Sutton G, Ng PC, et al., "The diploid genome sequence of an individual human," PLoS Biol, 5:e254, 2007.
17. Kidd JM, Cooper GM, Donahue WE et al., "Mapping and sequencing of structural variation from eight human genomes," Nature, 453:56-64, 2008.
18. Schulze JJ, Lundmark J, Garle M et al., "Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation," J. Clin. Endocrinol. Metab, doi:10.1210/jc.2008-0218, published on-line, March 11, 2008.
19. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440: 944-48.
20. Ohashi K, Ouchi N, Kihara S et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J. Am. Coll. Cardiol., 2004, 43:1195-1200.
21. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all cause, cardiovascular and cancer mortality.Sixteen years of follow-up in US women.Circulation 2008, doi:10.1161/CIRCULATIONAHA.107.739714.
22. Harris WS, Reid KJ, Sands SA, et al. Blood omega-3 and trans fatty acids in middle aged acute coronary syndrome patients. Am. J. Cardiol. 2007;99:154-158161.
23. Singh RBNiaz MA, Kartik C.Can omega-3 fatty acids provide myocardial protection by decreasing infarct size and inhibiting atherothrombosis? Euro Heart J.,2001,Vol 3,Supple):D62-D69.
24. Harper CR,Jacobson TA.Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Amer. J. Cardiol. 2005,96:1521-29.
25. Mozaffarian D,Geelan A,Brouwer IA et al.Effect of fish oil on heart rate in humans,a metaanalysis of randomized,controlled trials. Circulation 2005;112:1945-1952.
26. Jiang Z,Sim JS.Consumption of polyunsaturated fatty acid eggs and changes in plasma lipids of human subjects. Nutrition 2003,9:513-518.
27. Sumbalova Z,Kucharaska J,Kasparova S,Mlynarik V,Bystricky P,Bozek P,Ulicna O,Vancova O,Singh RB.Brain energy metabolism in experimental chronic diabetes:effect of long term administration of coenzyme Q10 and w-3 polyunsaturated fatty acids. Biologia,2005,11:1-13.
28. Zarranga IGE,Schwartz ER.Impact of dietary patterns and interventions on cardiovascular health. Circulation 2006,114:961-973.
29. Lacoix FCM, De Meester F. The return to wild types fats in the diet. Brit. Nutr. Founda Bull 2007, 32: 168-172.
30. Koide M, Kawahara Y, Tsuda T, Nakayama I, Yokoyama M. Expression of nitric oxide synthase by cytokines in vascular smooth muscle cells. Hypertension 1994, 23(Supple 1): 145-148.
31. Kang JX, Wank J, Wu I et al. Fat 1 mice convert n-6 to n-3 fatty acids.Nature 2004, 427: 304.
32. Lai L, Kang JX, Li R et al. Generation of cloned transgenic pigs rich in n-3 fatty acids. Nature Biotech 2006, 4:433-436.
33. Jump DB, Clarke SD,Theten A, Liimatta M, Ren B, Badin M. Dietary polyunsaturated regulation of gene transcription. Prog. Lipid Res. 1996, 35:227-241.
34. Takada R, Saitoh M, Mori T: Dietary gamma-linolenic acid enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid beta-oxidation in rats. J. Nutr. 1994 ; 124:469-474.
35. Power GW, Newsholme EA: Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyitransferase I in rat heart and sheletal muscle. J. Nutr. 1997;127:2142-2150.
36. Miller CC, Ziboh VA : Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE). J. Invest. Dermatol 94:353-358,1990.
37. Kidweel WR : Fatty acid growth requirements of normal and neoplastic mammary epithelium. Prog. Clin. Biol. Res. 1986;222:699-707.
38. Lambe KG, Tugwood JD: A human peroxisome-proliferator -activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drug. Eur. J. Biochem ,1996; 239:83-98.
39. Jump DB, Clarke SD, MacDougald OA, Thelen A: Polyunsaturated fatty acids inhibit S14 gene transcription in rat liver and cultured hepatocytes. Proc. Natl.Acad. Sci. USA ,1993;90:8454-8458.
40. Jump DB, Clarke SD,Thelen AT,Liimatta M: Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acid. J. Lipid Res. 1994; 35:1076-1084,.
41. Clarke SD, Jump DB : Fatty acid regulation of gene expression ; a unique role for polyunsaturated fats. In Berdanier CD, Hargrove JL(eds): "Nutrition and Gene Expression". Boca Raton, FL: CRC Reviews 1992; pp 227-245,
42. Desvergne B, Wahil W : Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999;20,649-688.
43. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D : Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 1998; 273: 8560-8563.
44. Rodriguez JC,Gil-Gomez B,Hegradt FG,Haro D: Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutary-CoA synthase gene by fatty acids, J. Biol. Chem. 1994; 269: 18767-18772.
45. Varanasi U,Chu R, Huang Q, Castellon R, Yeldandi AV, Reddy JK: Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl CoA oxidase gene. J. Biol. Chem. 1996; 271:2147-2155.
46. Aubert J, Champigny O, Saint-Marc P, Negrel R, Collins S, Ricquier D, Ailhaud G: Upregulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells. Biochem. Biophys. Res. Commun. 1997; 238:606-611.
47. Ye JM, Doyle PJ, Iglesias MA, Watson DG,Cooney GJ, Kraegen EWW. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipid and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 2001; 50: 411-417.
48. Guerre-Millo, M, Gervois P, Raspe E, Madsen E, Poulain P, Derudas B, Gerbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK,Staels B: Peroxisome proliferator-activated improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 2000; 275: 16638-16642.
49. Storlien L, Hulbert AJ, and Else PL: Polyunsaturated fatty acids, memberane function and metabolic diseases such as diabetes and obesity. Curr.Opin Clin. Nutr.Metab.Care ,1998; 1:559-563.
50. DuplusE, Glorian M, and Forest C: Fatty acids regulation of gene transcription. J. Biol. Chem. ,2000; 275:30749-30752.
51. De Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perimann T : Docosahexaenoic acid , a ligand for the retinoid X receptor in mouse brain. Science ,2000; 290:2140-2144.
52. Hertz R,Magenheim J, Berman I, Bar-Tana J: Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature ,1997; 392:512-516.
53. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA,Bashmakov Y, Goldstein JL, Brown MS: Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c(SREBP-1c) gene by antagonizing ligand-dependent activation of theLXR. Proc. Natl. Acad. Sci. USA,2000; 98:6027-6032.
54. Hannah VC, Ou J ,Luong A, Goldstein JL, Brown MS: Unsaturated Fatty Acids Down-regulate SREBP Isoforms 1a and 1c by Two Mechanisms in HEK-293 Cells. J. Biol. Chem ,2001; 276:4365-4372.
55. DeBose-Boyd RA, Ou J, Goldstein JL, Brown MS: Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Pro. Natl. Acad. Sci USA, 2001; 98:1477-1482.
56. Osborne TF : Sterol Regulatory Element-binding Proteins (SREBPs): Key Regulators of Nutritional Homeostasis and Insulin Action. J. Biol. Chem ,2000; 275:32379-32382.
57. Ren B Thelen AP, Peters JM,Gonzalez FJ, Jump DB: Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression dose not require peroxisome proliferator-activated receptor alfa. J. Biol. Chem,1997; 272:26827-26832.
58. Xu J, Nakamura MT,Cho HP, Clarke S: Sterol Regulatory Element Binding Protein-1 Expression Is Suppressed by Dietary Polyunsaturated Fatty Acids. J. Biol. Chem. 1999; 274:23577-23583.
59. Kim HJ, Takahashi M, Ezaki O : Fish Oil Feeding Decreases Mature Streol Regulatory Element-binding Protein 1 (SREBP-1) by Down-regulation of SREBP-1c mRNA in Mouse Liver. J. Biol. Chem, 1999; 274:25892-25898.
60. Mater MK, Thelen AP, Pan DA, Jump DB : Sterol Response Element-binding Protein 1c (SREBP 1c) is Involved in the poly-unsaturated fatty acid suppression of Hepatic S14 Gene Transcription. J. Biol. Chem, 1999; 274:32725-32732.
61. Hertz R, Magenheim J, Berman I, Bar-Tana J: Fatty acid-CoA esters are ligands of hepatic nuclear factor-4. Nature ,1998; 392:512-516.
62. Liimatta M, Towle HC, Clarke SD, Jump DB : Dietary polyunsaturated Fatty acids interfere with the insulin/glucose activation of L-type pyruvate kinase gene transcription. Mol. Endocrinology, 1999; 8:1147-1153.
63. Van der Kils FR, Schmidt ED,van Beeren HC, Wiersinga WM: Competitive inhibition of T3 binding to alpha 1 and beta 1 thyrroid hormone receptors by fatty acids. Biochem. Biophys. Res. Commun, 1991; 179:1011-1016.
64. Juge-Aubry CE, Gorla-Bajsczak A, Pernin A, Lemberger T, Wahli W, Burger AG, Meier CA: Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem. 1995; 270:18117-18122.
65. Singh RB,Singh V, Kulshrestha SK et al.Social class and all cause mortality in an urban population of North India. Acta Cardiol. 2005,60:611-617.
66. Katcher HI, Legro RS, Kunselman AR et al. The effects of whole grain- enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am. J. Clin. Nutr. 2008, 87:79-90.
67. DeMeester F, Wild-type land based foods in health promotion and disease prevention: the LDL-CC:HDL-CC model. In Wild Type Foods in Health Promotion and Disease Prevention, editors Fabien DeMeester and RR Watson, Humana Press,NJ 2008,p 3-20.
68. Fung TT, Chiuve SE, McCullough ML,Rexrode KM, Logroscino G, Hu FB. Adherance to DASH-style diet and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 2008, 168: 713-720.
69. Ulrev CL,Liu L, Andrews LG et al. The impact of metabolism on DNA and methylation .Hum. Mol. Genet 2005;14(supple 1)139-147.
70. Ander BP,Hurtado C, Raposo CS et al. Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to á-linolenic acid. Cardiovascular Research 73 (2007) 395-403.
71. Doria et al.Poor glycemic control modifies 9p21 varient coronary artery disease risk association. JAMA 2008, 300: 2389-2397.